Eli Lilly

News

Closeup of X-ray photography of human brain

Lilly focuses on tau with AC Immune Alzheimer's R&D tie-up

Eli Lilly has paid $81m to develop drugs targeting aggregation of tau proteins associated with Alzheimer’s with Swiss biotech AC Immune, as focus shifts away from therapies targeting clumps

News

Novo Nordisk's diabetes pill clears cardiac safety hurdle

Novo Nordisk is set to file its daily semaglutide type 2 diabetes pill after it cleared a phase 3 trial assessing its cardiac safety, with results showing it also reduced risk of cardiovasc

News

Lilly files new class migraine drug with FDA

Eli Lilly has filed a new migraine drug, lasmiditan, with the US regulator, the first drug in its class to be reviewed as a treatment for the condition.

News

Teva slumps after Express Scripts funds migraine rivals in U...

A major prescription benefit manager in the US will not reimburse Teva’s preventative migraine drug Ajovy (fremanezumab), in an effort to cut costs.

News

Lilly unveils promising data from dual-action diabetes drug

Eli Lilly’s investigational diabetes drug has shown early promise as a possible aid to overcoming obesity in trial results announced this week.

News

Lilly's breast cancer drug Verzenio approved in EU

Eli Lilly’s Verzenio breast cancer drug has been approved in Europe, as the pharma prepares to compete with established rivals from Pfizer and Novartis.

Lilly focuses on tau with AC Immune Alzheimer's R&D tie-up

Novo Nordisk's diabetes pill clears cardiac safety hurdle

Lilly files new class migraine drug with FDA

Teva slumps after Express Scripts funds migraine rivals in U...

Lilly unveils promising data from dual-action diabetes drug

Lilly's breast cancer drug Verzenio approved in EU

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Eli Lilly

Editor's Picks